Search Results

Rosie Dawaliby "I’m an expert in early-stage drug discovery, targeting membrane proteins, especially GPCR. In 2016, I joined a company that specialized in therapeutic candidate discovery targeting GPCR ( Confo Therapeutics ) as a team and project leader for antibody discovery for metabolic and inflammatory diseases GPCR Podcast? Leave a Review.

How GPCR genetic variants shape psychiatric drug response - Hauser on pharmacogenomics, the iPSYCH biobank Pharmacogenomics and Precision Psychiatry GPCR drug targets carry genetic variation that is far more to study how human genetic variation in GPCR drug targets shapes drug response and disease risk at a Hauser's work identified that variants are continuously arising across GPCR drug targets and likely contribute to adverse drug reactions through several distinct mechanisms.

Oliver Hartley Oliver Hartley is VP for Drug Discovery at Orion Biotechnology . He is the inventor of OB-002 as well as the key technology underlying Orion’s discovery platform. GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

She trained in high-throughput drug discovery at Vanderbilt - contributing to early functional assay discovery to NIH postdoc to independent lab 07:31 Alcohol disrupts mGlu2 in adolescent mice - and a still good drug targets? Discovery, the National Institute of General Medical Sciences, and the National Institute on Alcohol GPCR Podcast? Leave a Review.

at FFA2, and the pharmacogenomics gap in drug discovery. << Back to podcast list Strategic Partner(s unexplored opportunity in existing drug pipelines Antibody therapeutics for GPCRs - the pipeline case Gilchrist has argued for disease-relevant cell systems for over 15 years, and her lab's discovery of Pharmacogenomic variation in GPCRs may already be shaping clinical drug response - unacknowledged A paper Almost no company with an approved GPCR-targeting drug has gone back to look at what common receptor

he led contract research efforts at Biosym Technologies to develop and apply computational tools for drug discovery. co-founded and serves as board chair at Radionetics Oncology, a pharmaceutical company focused on the discovery GPCR Ecosystem Unlock the Full Dr. GPCR Podcast? Leave a Review.

<< Back to podcast list Strategic Partner(s) You never know where your GPCR takes you with Dr. He has more than 20 years of experience in GPCR, primarily focused on drug discovery and developing new leads a research group that is focused on understanding the pharmacology and function of a group a GPCRs GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

Robert Laprairie is an Associate Professor and the Saskatchewan Research Chair in Drug Discovery and GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

Understanding this complexity is essential for modern drug discovery. Absence of a Signal Can Be a Discovery One of Dr. Scientific Discovery Requires Intellectual Independence Dr. muscle growth 17:30 Early research on brown adipose tissue and thermogenesis 22:30 Translating academic discoveries “Sometimes the most important discovery is when a signal is missing.”

GPCR pharmacologist Dr. structural stabilization and live-cell conformational reporting The limits and promise of biased agonism in drug discovery Methodological triangulation — pairing static structures with dynamic measurements and cellular The neat bifurcation between G-protein and beta-arrestin signaling that drove early opioid receptor drug GPCR Podcast? Leave a Review.

Karine Pichavant , I contributed to the development of a drug to treat hypovolemic shock after severe Cone was the first to clone the melanocortin receptors (the GPCRs that led to the discovery of MRAP2) In-vivo techniques, I adapted my arrestin recruitment assay to a high throughput screening format for drug discovery, I have started molecular work on the melanocortin receptors. GPCR Unlock the Full Dr.

and the immune system, and the molecular mechanisms underlying the signaling and regulation of their GPCRs Excellerate is involved in several pre-clinical drug discovery projects for both GPCR and non-GPCR targets GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

GPCR Ecosystem. Get guidance, strategies, and insights to optimize your GPCR research and drug discovery projects. Any CRO focused on GPCRs, pharmacology, discovery biology, or antibody discovery—regardless of size or Power My Discovery Send me a message First name* Last name Company name* Email* How Can I Help? Let’s talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution

He has been also studying what aspects of GPCR signaling are regulated in a sex-selective manner and how this can influence drug discovery in the area of neurodegenerative diseases. GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

Articles About Log In / Sign Up Equip Your Team with Terry Kenakin’s Pharmacology Frameworks Used by discovery Shared pharmacology discipline for discovery teams. off annual access. $2,249.25 per person / year Activate Team Membership Why Teams Use Terry’s Corner Discovery • Pharmacology frameworks used in modern drug discovery • Monthly live AMA discussions with Terry Kenakin analysis • Ability to suggest topics relevant to your programs • Access for biotech, pharma, and academic discovery

His interests are in receptor pharmacology, allosteric protein function, and drug discovery. Dr. GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

approved drugs may still be getting wrong. << Back to podcast list Strategic Partner(s) Debbie Hay: RAMP is present, and those distinctions determine ligand selectivity, signaling output, and ultimately drug RAMPs since they were first described and when working on them was a high-risk research bet, the CGRP drug the two receptor complexes, combined with the known pharmacology of CGRP at CTR-RAMP1, suggest the drug still good drug targets - and what is missing from class B pharmacology 31:41 Reproducibility, target

matches — is non-trivial, and it matters for anyone hoping to translate kidney OR biology into a human drug Established assumptions about where a receptor "belongs" are often what stop a discovery from being recognized GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

Umeå, Sweden), I broadened my methodical and scientific horizon and focused on cellular metabolism and drug Metabolite Activation of GPCRs: A Fascinating Discovery Claudia and Yamina discussed the role of metabolites in activating GPCRs, a process that they found fascinating. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

They also discussed the ongoing developments in the GPCR field, the upcoming adhesion GPCR consortium Demet explained that since the year 2000, the field has seen significant growth, with important discoveries adhesion GPCRs. also discussed the importance of the extracellular region of these receptors and its potential as a drug GPCR Podcast? Leave a Review.

Lauren Slosky is an Assistant Professor in the Department of Pharmacology and a member of the Medical Discovery within the University of Minnesota’s Medical School to advance research and treatment in the field of drug GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

targets in metabolic disease - yet the signaling logic separating the therapeutic benefit of existing drugs the Guest Elva Zhao is a Research Fellow at the Monash Institute of Pharmaceutical Sciences (MIPS), Drug Discovery Biology, in Melbourne, Australia. receptor, and whether that regulatory layer contributes to the therapeutic window problem that GLP-1 drug Why GLP-1 Drugs Still Produce Nausea - and What Biased Signaling Might Fix The GI side effects of GLP

GPCR Podcast! Explore the fascinating career journeys, groundbreaking discoveries, and impactful contributions of experts We discuss breakthrough discoveries, career paths in pharmacology and molecular biology, and how each If you’re working on exciting GPCR-related research — from structural biology to drug discovery — we’ GPCR Podcast with three major goals in mind: Share the latest scientific discoveries in the GPCR field

pneumocytes, beta-2 receptors, and the asthma parallel The ethics of acting on conviction — off-label drug gas pedals and brakes" frame — a lens that has quietly shaped how he reads both disease mechanism and drug GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

target for drug development. and drug development technology. GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

whether they can ever be drugged. postdoc decision that defined the lab 17:43 Frizzled receptors: 10 subtypes, 19 ligands, almost no drugs ultimate aim is to use the new knowledge to find, create and optimize Frizzled-targeting small molecule drugs GPCR Ecosystem Unlock the Full Dr. GPCR Podcast? Leave a Review.

<< Back to podcast list Strategic Partner(s) GPCR location matters with Dr. In my PhD, I studied the nanoscale spatial organization of G protein-coupled receptors (GPCRs) at the revealed heterogeneous spatial patterns of receptor density and activation, that are modulated in a drug-dependent GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

how this can influence drug discovery in the area of neurodegenerative diseases. GPCR About Victoria Rasmussen "Victoria Rasmussen is a graduate fellow in Dr. GPCR Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

<< Back to podcast list Strategic Partner(s) Exploring Career Paths in GPCR Research with Dr. name mispronunciations, cultural differences, and the importance of a multidisciplinary approach in drug discussed their professional backgrounds, highlighting the benefits of a multidisciplinary approach in drug GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

into the structure, dynamics, and function of important classes of membrane proteins and prominent drug To this end, her lab uses several computational structural biology tools and rational drug design approaches GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.